drugset / Trial / NCT02634489

EC905 Pharmacokinetic Profile Study

NCT02634489

Phase 1 Completed 46 enrolled Astellas Pharma Europe B.V.
RandomizedCrossoverOpen-labelBasic science

Summary

A study to compare the pharmacokinetics of tamsulosin HCl and solifenacin succinate after co-administration of single entity tablets and of the combination tablet EC905 under steady state conditions at three dose strengths.

Timeline

Start
2009-03
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator EC905 Unknown Oral
Comparator Solifenacin Small molecule Oral
Comparator Tamsulosin Other / unclassified Oral